SHIONOGI & CO LTD (SGIOF) research
SHIONOGI & CO LTD- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Last price
- $16.39
- As of
SHIONOGI & CO LTD (SGIOF): no institutional manager tracked by Kresmion reported a non-option position in the latest Form 13F reporting quarter, and no SEC filing for the company is on record.
As of . Source: SEC EDGAR filings for SGIOF. Method and limitations.
Share the SGIOF intelligence card
See the full SGIOF dossier
Price with insider and filing markers, who is positioning, fundamentals and peers for SGIOF on one page. Preview it with sample data, then open it live with a free account.
Preview the SGIOF dossierActive signals for SGIOF
- mediumEARNINGS_BEAT
Q1-2027: Beat consensus by 149.6%, EPS $114.78 vs $45.9866 estimate
- mediumEARNINGS_BEAT
Q4-2026: Beat consensus by 22.6% - EPS $55.153 vs $44.998 estimate
- mediumEARNINGS_BEAT
Q1-2026: Beat consensus by 11.8% - EPS $46.26075 vs $41.3911 estimate
- mediumEARNINGS_BEAT
Q3-2026: Beat consensus by 37.4% - EPS $87.76173 vs $63.8752 estimate
- mediumEARNINGS_BEAT
Beat consensus by 22.6% - EPS $55.153 vs $44.998 estimate
FREE, NO ACCOUNT
Every signal on SGIOF, as it fires
New filings, 13F moves and cross asset signals on SGIOF land in the record first.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
No non-option holdings from tracked managers in this reporting quarter. Historical quarters remain available above.
Related tickers
See more SGIOF signals as they fire
Kresmion publishes filings, 13F flows, on-chain whale activity, and cross-asset signals in real time. Open a live board scoped to SGIOFand get the insider, 13F, options, and confluence read in one view.